Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 P534 | DOI: 10.1530/endoabs.81.P534

ECE2022 Poster Presentations Adrenal and Cardiovascular Endocrinology (87 abstracts)

Reevaluation of the 1-mg overnight low-dose dexamethasone suppression test in the diagnosis of Cushing’s syndrome

Cyrine Chehaider , Ibtissem Oueslati , Amani Terzi , Meriem Yazidi & Melika Chihaoui


La Rabta University Hospital, Department of Endocrinology, Tunis, Tunisia


Introduction: The 1-mg overnight low-dose dexamethasone suppression test is used as a screening tool when Cushing’s syndrome is suspected. However, the biological confirmation of this syndrome is based upon the measurement of 24-hour urinary free cortisol and low-dose dexamethasone suppression test (Liddle test). The aim of this study was to assess the performance of the 1-mg overnight low-dose dexamethasone suppression test in the diagnosis of Cushing’s syndrome.

Methods: This was a retrospective study including patients admitted to our department for suspicion of Cushing syndrome between 2016 and 2021. Clinical and paraclinical data and results of 1-mg overnight low-dose dexamethasone suppression test and Liddle test were collected from medical records.

Results: Fifty-one patients (39 women and 12 men) were enrolled in this study with a mean age of 54.3 ± 15.4 years. The diagnosis Cushing’s syndrome was established in 28 patients and excluded in 23 patients. The median serum cortisol level after the 1-mg test was 7.65 μg/dL in patients with Cushing’s syndrome and 2.1 μg/dL in those without Cushing’s syndrome (P=0.001). It was positively correlated with serum cortisol level after the Liddle test (r=0.852, P<10-3) and ACTH level (r=0.621, P=0.001). The area under the ROC curve of serum cortisol level after the 1-mg test was 0.773. A cutoff value of 1.8 μg/dL had a sensitivity of 100% and a specificity of 26%. A cutoff value of 5 μg/dL was associated with the diagnosis of Cushing syndrome (Odds Ratio= 4.11, P=0.016) with a sensitivity of 64% and a specificity of 70%. A cutoff value of 9.9 μg/dL confirmed the diagnosis of Cushing’s syndrome in 100% of cases.

Conclusion: With a cutoff value of 1.8 μg/dL, the 1-mg overnight low-dose dexamethasone suppression test is a reliable screening tool for Cushing’s syndrome. However, a higher cutoff value for serum cortisol (9.9 μg/dL) can be used alone to confirm the diagnosis. Further studies involving larger sample sizes would be useful to confirm our findings.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.